4/A: Inspire Medical Systems CEO Timothy Herbert Reports Amended SEC Filing Detailing Stock Sales Under 10b5-1 Plan

Timothy Herbert, CEO and President of Inspire Medical Systems, filed an amended SEC Form 4/A detailing multiple sales of common stock held indirectly through trusts and an LLC, executed on April 1, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• Timothy P. Herbert, CEO and President of Inspire Medical Systems, filed an amended SEC Form 4/A on April 3, 2024, related to transactions on April 1, 2024.
• The filing reports the sale of Inspire Medical Systems common stock held indirectly through the Timothy P. Herbert 2018 Family Continuation Trust, the TPH 2022 LLC, and the Timothy P. Herbert 2013 Family Irrevocable GST Trust.
• The sales were executed under a Rule 10b5-1 trading plan dated August 28, 2023.
• Multiple transactions occurred on April 1, 2024, with sale prices ranging from $202.785 to $213.99 per share.
• A total of 9,690 shares were sold directly.
• Following the reported transactions, Herbert indirectly owns 63,658 shares through the Family Continuation Trust, 117,658 shares through the LLC, and 115,731 shares through the Family Irrevocable GST Trust.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it reports insider selling under a pre-arranged plan, which is a common and legal practice. It doesn't necessarily indicate a negative outlook for the company.

Industry Context

Insider sales are a common occurrence, and the use of a 10b5-1 trading plan suggests the sales were pre-planned and not based on any specific non-public information. Investors often monitor insider transactions for signals about a company's prospects, but sales under a 10b5-1 plan are generally viewed as less informative.

Comparison to Industry Standards

• Comparing Herbert's transactions to other medical device company executives' trading activity would provide context.
• Analyzing the frequency and size of insider sales at companies like Medtronic, Boston Scientific, or Stryker could offer a benchmark.
• Reviewing the adoption and utilization of 10b5-1 plans among peer companies would also be relevant.

Stakeholder Impact

• The stock sales could have a minor negative impact on shareholder sentiment, although the existence of a 10b5-1 plan mitigates this concern.
• The transactions do not directly impact employees, customers, suppliers, or creditors.

Key Dates